Dr Elizabeth Hovey

Honorary Associate
NHMRC Clinical Trials Centre, Sydney Medical School

Telephone

+61 2 93822577

Fax

+61 2 9822588

Email

Map

Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma: the CODEL trial; Hovey E, Nowak A, Simes R, McDonald K, Drummond K, Buckland M, Koh E, Cher L; Cancer Council New South Wales/Research Project Grants.
A 2:1 Randomised Phase II Study of NivolUmab and Temozolomide vs Temozolomide in Methylated newly diagnosed Elderly Glioblastoma (NUTMEG); Khasraw M, McDonald K, Rosenthal M, Ellingson B, Ashley D, Barnes E, Hovey E, Foote M, Yip S, Goh C; National Health and Medical Research Council (NHMRC)/Project Grants.

COGNO infrastructure funding for support, development and conduct of clinical trials and translational research; Hovey E, Simes R, Koh E, Agar M, McDonald K, Wheeler H; Cancer Institute New South Wales/Cooperative Clinical Trial (CCT) Grants.

Download citations: PDF RTF Endnote

Journals

Agar, M., Koh, E., Gibbs, E., Barnes, E., Hovey, E., Livingstone (nee Ratcliffe), A., Sawkins, K., Chye, R., Lovell, M., Clark, K., Vardy, J., King, M. (2016). Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity. Supportive Care in Cancer, 24(3), 1209-1218. [More Information]
Hovey, E., De Souza, P., Marx, G., Parente, P., Rapke, T., Hill, A., Bonaventura, A., Michele, A., Craft, P., Abdi, E., et al (2014). Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy. Supportive Care in Cancer, 22(5), 1233-1242. [More Information]
Grimison, P., Houghton, B., Chatfield, M., Toner, G., Davis, I., Martin, J., Hovey, E., Stockler, M. (2013). Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer. BJU International, 112(2), E35-E43. [More Information]
Kao, S., Hovey, E., Marx, G. (2011). Second-line therapy for castrate-resistant prostate cancer: A literature review. Asia-Pacific Journal of Clinical Oncology, 7, 212-223. [More Information]

2016

Agar, M., Koh, E., Gibbs, E., Barnes, E., Hovey, E., Livingstone (nee Ratcliffe), A., Sawkins, K., Chye, R., Lovell, M., Clark, K., Vardy, J., King, M. (2016). Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity. Supportive Care in Cancer, 24(3), 1209-1218. [More Information]

2014

Hovey, E., De Souza, P., Marx, G., Parente, P., Rapke, T., Hill, A., Bonaventura, A., Michele, A., Craft, P., Abdi, E., et al (2014). Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy. Supportive Care in Cancer, 22(5), 1233-1242. [More Information]

2013

Grimison, P., Houghton, B., Chatfield, M., Toner, G., Davis, I., Martin, J., Hovey, E., Stockler, M. (2013). Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer. BJU International, 112(2), E35-E43. [More Information]

2011

Kao, S., Hovey, E., Marx, G. (2011). Second-line therapy for castrate-resistant prostate cancer: A literature review. Asia-Pacific Journal of Clinical Oncology, 7, 212-223. [More Information]

To update your profile click here. For support on your academic profile contact .